Imperial Innovations Group plc is pleased to note that its portfolio company Cell Medica has today announced the start of commercial cell therapy manufacturing at its facility at the Max-DelbrA1 4ck-Center of Molecular Medicine in Berlin-Buch . The first product has been successfully manufactured and delivered for use in the patient.
http://ift.tt/1G8DFEm
http://ift.tt/1G8DFEm
No comments:
Post a Comment